Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.
暂无分享,去创建一个
P. Flamen | V. Donckier | B. Vanderlinden | Camilo Garcia | P. Demetter | V. Lucidi | A. Hendlisz | M. Vouche | A. Deleporte | G. Katsanos | H. Levillain | M. G. Galdon | P. Delatte | F. Bouazza | M. Lemaire | C. Garcia
[1] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[2] W. Lau,et al. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres , 2017, Annals of Surgical Oncology.
[3] A. Rademaker,et al. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.
[4] C. Peng,et al. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials , 2016, Scandinavian journal of gastroenterology.
[5] M. Abecassis,et al. 90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes , 2016, Journal of surgical oncology.
[6] Jeong Won Lee,et al. Prognostic Significance of 18F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study , 2016, The Journal of Nuclear Medicine.
[7] M. Makuuchi,et al. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. , 2015, The Lancet. Oncology.
[8] P. Flamen,et al. Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. , 2015, World journal of gastroenterology.
[9] K. Tatsch,et al. Liver resection after selective internal radiotherapy (SIRT): Proof of concept, initial survival, and safety , 2015, Journal of surgical oncology.
[10] A. Russo,et al. Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis , 2015, PloS one.
[11] O. Shibolet,et al. [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco‐ablative therapies for hepatocellular carcinoma , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] A. Luciani,et al. Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis. , 2015, Journal of hepatology.
[13] T. Nishidate,et al. Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system. , 2014, World journal of hepatology.
[14] J. Bruix,et al. Treatment of intermediate-stage hepatocellular carcinoma , 2014, Nature Reviews Clinical Oncology.
[15] A. Darzi,et al. Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis. , 2014, World journal of gastroenterology.
[16] M. Abecassis,et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. , 2013, Journal of hepatology.
[17] Carlo Morosi,et al. Yttrium‐90 radioembolization for intermediate‐advanced hepatocellular carcinoma: A phase 2 study , 2013, Hepatology.
[18] K. Boudjema,et al. Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting? , 2013, Annals of Surgical Oncology.
[19] P. Chow,et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria , 2012, The British journal of surgery.
[20] B. Sangro,et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] K. Okazaki,et al. A Prospective Randomized Controlled Trial of Preoperative Whole-Liver Chemolipiodolization for Hepatocellular Carcinoma , 2012, Digestive Diseases and Sciences.
[22] Riccardo Lencioni,et al. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.
[23] F. Izzo,et al. Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation , 2011, Hepatology.
[24] M. Schwartz,et al. Second hepatic resection for recurrent hepatocellular cancer: a Western experience. , 2011, Journal of hepatology.
[25] K. McMasters,et al. Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. , 2011, The Journal of surgical research.
[26] A. Benson,et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. , 2011, Gastroenterology.
[27] K. McMasters,et al. Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[28] L. Schwartz,et al. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] M. Abecassis,et al. A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[30] M. Abecassis,et al. Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization , 2009, Annals of Surgical Oncology.
[31] G. Cabibbo,et al. Multimodal approaches to the treatment of hepatocellular carcinoma , 2009, Nature Clinical Practice Gastroenterology &Hepatology.
[32] W. Lau,et al. A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.
[33] Y. Fong,et al. Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections , 2009, World journal of surgical oncology.
[34] D. Larsimont,et al. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres. , 2008, Clinical nuclear medicine.
[35] M. Abecassis,et al. Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.
[36] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[37] M. Makuuchi,et al. Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma , 2003, Annals of surgery.
[38] H. Hsu,et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. , 1996, Surgery.
[39] F. P'eng,et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal , 1995, The British journal of surgery.